[Value of 1694 for children with cerebral palsy of those presenting psychomotor development disorders].
D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011596:Psychomotor Disorders / Q000188:drug therapy*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000644:Quaternary Ammonium Compounds; D014149:Tranquilizing Agents
Interêt du 1694 chez les enfants infirmes moteurs cérébraux, ou présentant un trouble de développement psycho-moteur